Infinity Pharmaceuticals | INFI - Assets


Infinity Pharmaceuticals reported $21.23M in Assets for its fiscal quarter ending in June of 2023.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 39.4B 957M Jun/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Incyte USD 6.96B 627.62M Dec/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Plus Therapeutics USD 11.39M 1.89M Dec/2023
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.03B 322.41M Sep/2025